News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Polu Krishna R
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 11/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/17/2020 |
3/A
| Polu Krishna R (Director) has filed a Form 3/A on Frazier Lifesciences Acquisition Corp |
| 12/08/2020 |
3
| Polu Krishna R (Director) has filed a Form 3 on Frazier Lifesciences Acquisition Corp |
| 04/24/2020 |
4
| Polu Krishna R (Chief Medical Officer) has filed a Form 4 on Equillium, Inc.|
Txns:
| Disposed/sold 208,216 options to buy
@ $3.3, valued at
$687.1k
Granted 208,216 options to buy
@ $2.45, valued at
$510.1k
Disposed/sold 90,000 options to buy
@ $7.16, valued at
$644.4k
Granted 90,000 options to buy
@ $2.45, valued at
$220.5k
Disposed/sold 125,000 options to buy
@ $4.75, valued at
$593.8k
Granted 125,000 options to buy
@ $2.45, valued at
$306.3k
|
|
| 12/12/2019 |
4
| Polu Krishna R (Chief Medical Officer) has filed a Form 4 on Equillium, Inc.|
Txns:
| Granted 125,000 options to buy
@ $4.75, valued at
$593.8k
|
|
| 02/15/2019 |
4
| Polu Krishna R (Chief Medical Officer) has filed a Form 4 on Equillium, Inc.|
Txns:
| Granted 90,000 options to buy
@ $7.16, valued at
$644.4k
|
|
| 10/11/2018 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 10/26/2016 |
4
| Polu Krishna R (Chief Medical Officer) has filed a Form 4 on Raptor Pharmaceutical Corp|
Txns:
| Disposed/sold 23,781 shares
@ $9, valued at
$214k
Disposed/sold 89,152 options to buy
@ $3.74, valued at
$333.4k
|
|
| 02/11/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|